Kalinga Hospital
Bhubaneswar, Orissa, India
Private hospital in Bhubaneswar, Odisha
Nalco Square, NALCO Nagar, Chandrasekharpur, Bhubaneswar, Odisha 751023
About Kalinga Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Kalinga Hospital
During the past decade, Kalinga Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
2003-04-01
Unknown status
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
2006-10-01
2011-04-01
Completed
349
Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma
2004-12-01
2010-06-01
Completed
67
A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
2011-04-04
2014-03-28
Terminated
338
A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer
2015-01-20
2020-08-14
Completed
645
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
2017-02-03
2019-12-26
Completed
326
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
2017-10-04
2025-04-23
Recruiting
336
ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19
2020-11-03
2021-05-31
Terminated
133
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kalinga Hospital"
#1 collaborator was "All India Institute of Medical Sciences, New Delhi" with 2 trials as a collaborator, "Bill and Melinda Gates Foundation" with 2 trials as a collaborator, "Capital Hospital, Bhubaneswar" with 2 trials as a collaborator, "Department of Health and Family Welfare, Orissa" with 2 trials as a collaborator and "Fogarty International Center of the National Institute of Health" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Kalinga Hospital
According to Clinical.Site data, the most researched conditions in "Kalinga Hospital" are
"Sepsis" (2 trials). Many other conditions were trialed in "Kalinga Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kalinga Hospital
Most popular intervention types in "Kalinga Hospital" are "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Probiotic supplementation (Lactobacillus plantarum)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kalinga Hospital
The vast majority of trials in "Kalinga Hospital" are
2 trials for "All" genders.
Clinical Trials Status at Kalinga Hospital
Currently, there are NaN active trials in "Kalinga Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Kalinga Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kalinga Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".